REGENXBIO Inc.
$644.27M- Market cap
- $590.16M
- Debt
- +$284.18M
- Cash
- −$230.07M
Capital structure 67% equity / 33% debt · EV / Revenue 3.78x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
RGNX · current priceP/S 3.46x
$8.94Latest market snapshot
Implied fair value · at SWKS's multiple
$7.0421.3% below market
2.58 RGNX revenue / share×2.73x SWKS P/S=$7.04
Market $8.94Implied $7.04
SWKS · current priceP/S 2.73x
$74.02Latest market snapshot
Implied fair value · at RGNX's multiple
$94.0427.1% above market
27.16 SWKS revenue / share×3.46x RGNX P/S=$94.04
Market $74.02Implied $94.04